#glp-1-agonists

[ follow ]
#ozempic #weight-loss-drugs #weight-loss #semaglutide #drug-pricing #white-house #medical-emergency
fromFuturism
1 week ago

Pharma Exec Collapses During White House Event on Drug Prices

Live TV coverage of the event shows Novo Nordisk executive Gordon Findlay slumping to the floor inside the Oval Office, with several men nearby helping to guide his body safely to the ground. Medicare and Medicaid administrator Mehmet Oz grabbed Findlay under the shoulders to help him to the ground. Trump stands up from behind his desk in the Oval Office, but doesn't intervene. Health secretary Robert Kennedy Jr. can be seen walking briskly away from Findlay.
US politics
Public health
fromwww.npr.org
2 weeks ago

Weight loss drugs are bringing down the country's obesity rate, a survey shows

Rapidly rising use of injectable GLP-1 drugs corresponds with a decline in U.S. adult obesity rates to 37%.
#ozempic
fromBuzzFeed
1 month ago
Medicine

My Incurable Condition Is A Potential Ozempic Side Effect. Trust Me - Weight Loss Isn't Worth This.

fromBuzzFeed
1 month ago
Medicine

My Incurable Condition Is A Potential Ozempic Side Effect. Trust Me - Weight Loss Isn't Worth This.

more#ozempic
Medicine
fromwww.theguardian.com
2 months ago

Weight loss drugs can halve heart patients' risk of early death, study finds

GLP-1 agonist weight-loss drugs substantially reduce hospitalization and premature death risk in obese heart failure patients with type 2 diabetes, up to 58%.
fromFuturism
3 months ago

The Creator of Ozempic Is in Terrible Trouble

Novo Nordisk, creator of the mega-hit drug Ozempic, has seen a loss of nearly $100 billion in market value due to collapsing sales and missed forecasts.
Healthcare
Health
fromFuturism
4 months ago

Doctors Are Warning That Ozempic's Severe Side Effects May Outweigh Its Benefits

GLP-1 weight loss drugs like Ozempic and Wegovy have concerning side effects, including potential vision impairment and increased risk of kidney problems.
Healthcare
fromFast Company
4 months ago

Wegovy and Zepbound prices are dropping, but steady access to the weight-loss drugs remains a challenge

Prices for Wegovy and Zepbound are decreasing, but access remains hindered by high costs and uneven insurance coverage.
fromNature
4 months ago

Obesity drugs show promise treating a new ailment: migraine

In a small study, the drug liraglutide reduced monthly migraine episodes by nearly half among people with obesity who experience the headache-inducing condition.
Alternative medicine
#weight-loss
more#weight-loss
[ Load more ]